Skip to main content

Intertrochanteric Fractures

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
Liposomal BupivicaineN/A1 trial
Active Trials
NCT07892859Completed80Est. Sep 2026
Arthrex
ArthrexCA - Santa Barbara
1 program
Telescoping Lag ScrewN/A1 trial
Active Trials
NCT05094791Completed60Est. Feb 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Integrated BiosciencesLiposomal Bupivicaine
ArthrexTelescoping Lag Screw

Clinical Trials (2)

Total enrollment: 140 patients across 2 trials

Liposomal Bupivacaine Fascia Iliaca Block for Perioperative Sleep Quality in Elderly Patients With Intertrochanteric Fracture

Start: Jan 2026Est. completion: Sep 202680 patients
N/ACompleted
NCT05094791ArthrexTelescoping Lag Screw

Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes

Start: Oct 2021Est. completion: Feb 202460 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.